Birmingham, West Midlands -- (SBWIRE) -- 12/27/2013 -- Value Penny Stocks issues special report on Dynavax Technologies Corporation (NASDAQ:DVAX), Dendreon Corporation (NASDAQ:DNDN), InfoSonics Corporation (NASDAQ:IFON), MannKind Corporation (NASDAQ:MNKD).
Dynavax Technologies Corporation (NASDAQ:DVAX) ended its recent business day with the loss of -3.00% and closed at the price of $1.94 after opening at $2.02. The stock traded during its last trading session with the total volume of 3,686,830 shares, as compared to its average volume of 5.74 million shares. Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases. It develops product candidates based on the use of immunostimulatory sequences and immunoregulatory sequences.
Has DVAX Found The Bottom and Ready To Move Up? Find Out Here
Dendreon Corporation (NASDAQ:DNDN) remained among the day decliners and traded with volume of 3,615,323 shares in the last session, as compared to average volume of 3.88 million shares. In comparison with 52 week range of $2.23 - $7.22, it faced lowest price of $3.23 during the last trading session whereas its day highest price was $3.39. The company’s total market capitalization is $516.56 billion, along with 157.49 million shares outstanding. Dendreon Corporation, a biotechnology company, engages in the discovery, development, and commercialization of novel therapeutics to enhance cancer treatment options for patients. Its product portfolio includes active cellular immunotherapy and small molecule product candidates to treat a range of cancers.
Has DNDN Found The Bottom And Ready To Gain Momentum? Find Out Here
InfoSonics Corporation (NASDAQ:IFON) showed 3,506,001 shares in volume during the last trading session, while the average trading volume remained 101,625.00 shares. The stock kicked off its trading session at $1.20 and closed at $1.81 after mounting 58.77%. InfoSonics Corporation designs, develops, manufactures, and sells wireless telecommunication products and accessories to wireless carriers, distributors, retailers, dealer agents, resellers, and original equipment manufacturers.
Will IFON Continue To Move Higher? Find Out Here
MannKind Corporation (NASDAQ:MNKD) stock traded during its last trading session with the total traded volume of 3,475,759 shares versus its average volume of 4.05 million shares. The company opened its trade at the price of $5.25 and its closing price was $5.30 after gaining 0.95% for the day. MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States.
Why Should Investors Buy MNKD After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)